Clinical trial
Tamoxifen in Treating Women With Breast Cancer
NCT00003678 · University Hospital Birmingham, Other · Unknown status
Key facts
| NCT number | NCT00003678 |
|---|---|
| Title | Tamoxifen in Treating Women With Breast Cancer |
| Official title | A Large, Uniquely Simple, Randomised Study to Assess Much More Reliably the Balance of Benefits and Risks of Prolonging Adjuvant Tamoxifen Treatment in Early Breast Cancer |
| Lead sponsor | University Hospital Birmingham, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure |
| Interventions | tamoxifen citrate, adjuvant therapy |
| Enrollment | 20,000 |
| Start date | May 1, 1991 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: